The FDA has authorized urcosimod 0.05% for single-patient expanded access, or compassionate use, in a patient with neuropathic corneal pain, according to a press release from Okyo.

At some point, you’ve probably heard the phrase, “It takes money to make money.” But if you’re not careful, it’s easy for expenses to spiral out of control — and you could end up making little to no ...

Discover the leading database management systems for enterprises in 2026. Explore key features, pricing, and implementation tips for selecting the best DBMS software to harness your data effectively.